Results 231 to 240 of about 38,473 (244)

Real‐Time Optimal Control of High‐Dimensional Parametrized Systems by Deep Learning‐Based Reduced Order Models

open access: yesInternational Journal for Numerical Methods in Engineering, Volume 127, Issue 1, 15 January 2026.
ABSTRACT Steering a system towards a desired target in a very short amount of time is a challenging task from a computational standpoint. Indeed, the intrinsically iterative nature of optimal control problems requires multiple simulations of the state of the physical system to be controlled. Moreover, the control action needs to be updated whenever the
Matteo Tomasetto   +2 more
wiley   +1 more source

A unified model for Duchenne muscular dystrophy gene involvement in cancer: context‐dependent tumour suppression and oncogenicity

open access: yesFEBS Open Bio, Volume 16, Issue 1, Page 222-236, January 2026.
We propose a context‐dependent model where the Duchenne muscular dystrophy (DMD) gene acts as a tumour suppressor in aggressive tumours and as an oncogene in less aggressive ones. We propose this model as a unified framework to explain the opposing survival associations with DMD expression and to guide experimental exploration of the dual role of DMD ...
Lee Machado   +4 more
wiley   +1 more source

Transcytotic transportation of size-controlled nanocarriers into dystrophic skeletal muscle leads to therapeutic outcome in mice. [PDF]

open access: yesNat Commun
Liu X   +16 more
europepmc   +1 more source

Proteomics of Duchenne Muscular Dystrophy Patient iPSC-Derived Skeletal Muscle Cells Reveal Differential Expression of Cytoskeletal and Extracellular Matrix Proteins. [PDF]

open access: yesCells
Gallert SM   +10 more
europepmc   +1 more source

Multiparametric cardiac magnetic resonance evaluation of myocardial involvement in Duchenne muscular dystrophy: A case report. [PDF]

open access: yesRadiol Case Rep
Takamure H   +8 more
europepmc   +1 more source

Humanin improves bone health in a glucocorticoid-treated mouse model of Duchenne muscular dystrophy. [PDF]

open access: yesBiochem Biophys Rep
Cedervall T   +7 more
europepmc   +1 more source

Caregiver-reported Patient Experiences with Duchenne Muscular Dystrophy: Qualitative In-trial Interviews 1 Year After Delandistrogene Moxeparvovec in the Pivotal EMBARK Trial. [PDF]

open access: yesNeurol Ther
Audhya I   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy